MedAvail to Present at the 39th Annual J.P. Morgan Healthcare Conference
MedAvail Holdings, Inc. (Nasdaq: MDVL) recently announced its participation in the 39th Annual J.P. Morgan Healthcare Conference. The presentation is set for January 14, 2021, at 3:40 p.m. Eastern Time. MedAvail focuses on enhancing medication adherence by integrating pharmacy services within Medicare clinics through its proprietary MedCenter solution. Interested individuals can access a live and archived webcast of the event on the company’s website.
MedAvail is dedicated to improving patient health outcomes by providing in-clinic pharmacy services.
- None.
- None.
MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled retail pharmacy company driving best in class medication adherence by embedding its pharmacy services directly into Medicare focused clinics using its proprietary MedCenter solution, today announced that the company will be participating in the upcoming 39th Annual J.P. Morgan Healthcare Conference.
MedAvail’s management is scheduled to present on Thursday, January 14, 2021 at 3:40 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at https://investors.medavail.com/.
About MedAvail
MedAvail Holdings Inc. (NASDAQ: MDVL) is a technology-enabled pharmacy organization, providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. MedAvail helps patients to optimize drug adherence, resulting in better health outcomes. Learn more at www.medavail.com.
SOURCE MedAvail Holdings Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210106005181/en/
FAQ
When is MedAvail's presentation at the J.P. Morgan Healthcare Conference 2021?
How can I watch the MedAvail presentation online?
What technology does MedAvail use for medication adherence?
What is the focus of MedAvail Holdings?